Insulin Delivery Devices Market by Type (Insulin Pens [Reusable, Disposable], Insulin Pumps (Tethered, Tubeless), Insulin Syringes, Insulin Pen Needles (Standard, Safety)), End User (Hospitals & Clinics, Patients/Homecare) - Global Forecast to 2028
The global insulin delivery devices market is projected to reach USD 46.2 billion by 2028 from USD 30.8 billion in 2023, at a CAGR of 8.5% during the forecast period. Growth in the insulin delivery devices market is mainly driven by factors such as the growing prevalence of diabetic population, government support and favorable reimbursement schemes, technological advancements in insulin delivery devices. On the other hand, the high costs and lack of reimbursements in developing countries of insulin delivery devices systems are expected to restrain market growth to a certain extent.
Insulin pumps segment is projected to grow at the highest CAGR during the forecast period By type, the global insulin delivery devices market is segmented into insulin pens, insulin pumps, insulin pen needles, insulin syringes and other insulin delivery devices which includes, transdermal insulin patch, insulin jet injectors, insulin inhalers. The insulin pump segment is further sub-segmented into tethered insulin pumps and tubeless insulin pumps. As newer and more refined technology has now revolutionized insulin pumps in terms of their quality of care, and ease of use resulting in improved glycemic control, in addition favourable reimbursement in developed countries is contributing towards the adoption of these devices as a result this segment is projected to have the highest CAGR in the forecast period.
Patients/Homecare end user segment is projected to grow at the highest CAGR during the forecast period By end users, the insulin delivery devices market is segmented into patients/ homecare and hospitals & clinics. The patients/home care segment is expected to grow at the highest CAGR during the forecast period. This is primarily attributed to the rising patient acceptance of home care as a result of growing awareness of diabetes care devices, increasing diabetic healthcare expenditure and favourable reimbursements.
By region, North America is projected to account for the largest share of the insulin delivery devices market
Based on region, the insulin delivery devices market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America dominated the insulin delivery devices market in 2022. The growth of connected diabetes management devices, the rising diabetic population, demand for technologically advanced products, government initiatives, and increasing awareness of self-diabetes management in the region are the main factors driving North America to dominate the insulin delivery devices market.
Breakdown of supply-side primary interviews: %li%By Company Type: Tier 1 – 46%, Tier 2 – 33%, and Tier 3 – 21% %li%By Designation: C-level – 43%, Director-level – 35%, and Others – 22% %li%By Region: North America - 34%, Europe – 26%, APAC –19%, Rest of World–21%
The prominent players operating in the global insulin delivery devices market are Embecta Corp. (Formely Becton, Dickinson and Company Diabetes Care Business (US), Ypsomed Holding AG (Switzerland), Tandem Diabetes Care (US), Insulet Corporation (US), Biocon Limited (India), Novo Nordisk A/S (Denmark), Medtronic (Ireland), Sanofi (France), Eli Lilly and Company (US), Roche Diabetes Care (Switzerland), Owen Mumford (England), Mrdtrum Technologies Inc. (China), Terumo Corporation (Japan), Wockhardt (India), Cerur Corporation (Switzerland), EoFlow CO., Ltd. (South Korea), Hindustan Syringes & Medical Devices Ltd (India), Sooil Developments CO., Ltd (Korea), Sungshim Medical Co., Ltd. (South Korea), Vicentra B.V. (Netherland), Debiotech SA (Switzerland), Jiangsu Delfu Medical Device Co., Ltd (China), Haselmeier (Germany), Mannkind Corporation (US), HTL-Sterfa S.A. (Poland).
Research Coverage
This report studies the insulin delivery devices market based on type, application, product, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
Insulin pumps segment is projected to grow at the highest CAGR during the forecast period By type, the global insulin delivery devices market is segmented into insulin pens, insulin pumps, insulin pen needles, insulin syringes and other insulin delivery devices which includes, transdermal insulin patch, insulin jet injectors, insulin inhalers. The insulin pump segment is further sub-segmented into tethered insulin pumps and tubeless insulin pumps. As newer and more refined technology has now revolutionized insulin pumps in terms of their quality of care, and ease of use resulting in improved glycemic control, in addition favourable reimbursement in developed countries is contributing towards the adoption of these devices as a result this segment is projected to have the highest CAGR in the forecast period.
Patients/Homecare end user segment is projected to grow at the highest CAGR during the forecast period By end users, the insulin delivery devices market is segmented into patients/ homecare and hospitals & clinics. The patients/home care segment is expected to grow at the highest CAGR during the forecast period. This is primarily attributed to the rising patient acceptance of home care as a result of growing awareness of diabetes care devices, increasing diabetic healthcare expenditure and favourable reimbursements.
By region, North America is projected to account for the largest share of the insulin delivery devices market
Based on region, the insulin delivery devices market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America dominated the insulin delivery devices market in 2022. The growth of connected diabetes management devices, the rising diabetic population, demand for technologically advanced products, government initiatives, and increasing awareness of self-diabetes management in the region are the main factors driving North America to dominate the insulin delivery devices market.
Breakdown of supply-side primary interviews: %li%By Company Type: Tier 1 – 46%, Tier 2 – 33%, and Tier 3 – 21% %li%By Designation: C-level – 43%, Director-level – 35%, and Others – 22% %li%By Region: North America - 34%, Europe – 26%, APAC –19%, Rest of World–21%
The prominent players operating in the global insulin delivery devices market are Embecta Corp. (Formely Becton, Dickinson and Company Diabetes Care Business (US), Ypsomed Holding AG (Switzerland), Tandem Diabetes Care (US), Insulet Corporation (US), Biocon Limited (India), Novo Nordisk A/S (Denmark), Medtronic (Ireland), Sanofi (France), Eli Lilly and Company (US), Roche Diabetes Care (Switzerland), Owen Mumford (England), Mrdtrum Technologies Inc. (China), Terumo Corporation (Japan), Wockhardt (India), Cerur Corporation (Switzerland), EoFlow CO., Ltd. (South Korea), Hindustan Syringes & Medical Devices Ltd (India), Sooil Developments CO., Ltd (Korea), Sungshim Medical Co., Ltd. (South Korea), Vicentra B.V. (Netherland), Debiotech SA (Switzerland), Jiangsu Delfu Medical Device Co., Ltd (China), Haselmeier (Germany), Mannkind Corporation (US), HTL-Sterfa S.A. (Poland).
Research Coverage
This report studies the insulin delivery devices market based on type, application, product, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
- Analysis of key drivers (growing prevalence of diabetic population, technological advancements in insulin delivery devices, government support and favourable reimbursement schemes to favour market growth), restraints (high cost and lack of reimbursement in developing countries, needle anxiety in patients to affect the growth of the pen needles and syringes market, oral insulin as an alternative drug delivery method), opportunities (increasing research and development activities and strategic partnerships, advances in syringe and technology) and challenges (Needle stick injuries and misuse of injection pens)
- Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global insulin delivery devices market
- Market Development: Comprehensive information on the lucrative emerging markets by type, end user, and region.
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global insulin delivery devices market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global insulin delivery devices market. This report also helps stakeholders understand the pulse of the molecular quality controls market and provides them information on key market drivers, restraints, challenges, and opportunities.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 INSULIN DELIVERY DEVICES MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2022)
FIGURE 6 MARKET SIZE ESTIMATION: COMPANY-WISE REVENUE SHARE ANALYSIS (2022)
FIGURE 7 INSULIN DELIVERY DEVICES MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF INSULIN DELIVERY DEVICES MARKET
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 IMPACT OF RECESSION
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS. 2021–2027 (%GROWTH)
3 EXECUTIVE SUMMARY
FIGURE 10 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 INSULIN DELIVERY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF INSULIN DELIVERY DEVICES MARKET
4 PREMIUM INSIGHTS
4.1 INSULIN DELIVERY DEVICES: MARKET OVERVIEW
FIGURE 13 INCREASING TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY DEVICES TO DRIVE MARKET
4.2 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE AND COUNTRY (2022)
FIGURE 14 INSULIN PENS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
4.3 INSULIN DELIVERY DEVICES MARKET: GEOGRAPHICAL MIX
FIGURE 15 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.4 INSULIN DELIVERY DEVICES MARKET: REGIONAL MIX (2023–2028)
FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD (2023–2028)
4.5 INSULIN DELIVERY DEVICES MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 17 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 INSULIN DELIVERY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of diabetic population
FIGURE 19 GLOBAL PREVALENCE OF DIABETES IN INDIVIDUALS AGED 20–79 YEARS, 2015–2021 (MILLIONS)
FIGURE 20 PROJECTION OF DIABETES FOR INDIVIDUALS AGED 20–79 YEARS, 2030-2045 (MILLIONS)
FIGURE 21 TOP TEN COUNTRIES WITH HIGHEST COUNT OF DIABETICS (20–79 YEARS), 2021 & 2045
5.2.1.2 Technological advancements in insulin delivery devices
FIGURE 22 ADVANCEMENTS IN INSULIN DELIVERY DEVICES
5.2.1.3 Government support and favorable reimbursement schemes to favor market growth
5.2.2 RESTRAINTS
5.2.2.1 High costs and lack of reimbursement in developing countries
5.2.2.2 Needle anxiety in patients to affect growth of pen needles and syringes market
5.2.2.3 Oral insulin as alternative drug delivery method
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing R&D activities and strategic partnerships
5.2.3.2 Increasing healthcare expenditure on diabetes care
FIGURE 23 TOTAL HEALTH EXPENDITURE ON DIABETES CARE, 2021–2045 (USD BILLION)
5.2.3.3 Advances in syringe and needle technology
5.2.3.4 Mandates pertaining to safety-engineered medical needles to encourage market growth
5.2.4 CHALLENGES
5.2.4.1 Needlestick injuries and misuse of injection pens
5.2.4.2 Lack of interoperability among insulin delivery devices
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 INSULIN DELIVERY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 INTENSITY OF COMPETITIVE RIVALRY
5.3.2 BARGAINING POWER OF SUPPLIERS
5.3.3 BARGAINING POWER OF BUYERS
5.3.4 THREAT OF SUBSTITUTES
5.3.5 THREAT OF NEW ENTRANTS
5.4 REGULATORY ANALYSIS
TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES
5.4.1 NORTH AMERICA
5.4.1.1 US
TABLE 4 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
FIGURE 24 FDA 510(K) APPROVAL PROCESS
5.4.1.2 Canada
5.4.2 EUROPE
FIGURE 25 CE MARK APPROVAL PROCESS FOR INSULIN DELIVERY DEVICES
5.4.3 ASIA PACIFIC
5.4.3.1 Japan
TABLE 5 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY
5.4.3.2 China
TABLE 6 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.3.3 India
TABLE 7 INDIA: MEDICAL DEVICE CLASSIFICATION
5.4.3.4 Australia
FIGURE 26 SUMMARY OF APPROVAL, ACCESS, AND DISTRIBUTION PATHWAYS FOR NEW TECHNOLOGY USED FOR INSULIN DRUG DELIVERY DEVICES
5.4.4 REST OF THE WORLD
5.5 INDUSTRY INSIGHTS
5.5.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS
TABLE 8 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO
5.5.2 SYNCHRONIZATION OF SMART INSULIN PENS WITH CGM SYSTEMS TO PROMOTE DIABETES DATA SHARING
TABLE 9 MAJOR SMART INSULIN PENS AVAILABLE GLOBALLY
5.5.3 INCREASING NUMBER OF COLLABORATIONS AMONG STAKEHOLDERS
TABLE 10 INSULIN DELIVERY DEVICE MARKET: RECENT COLLABORATIONS
5.6 REIMBURSEMENT SCENARIO
TABLE 11 INSULIN DELIVERY DEVICES: GLOBAL COVERAGE AND REIMBURSEMENT
5.6.1 US
5.6.2 CANADA
5.6.3 UK
5.6.4 AUSTRALIA
5.6.5 OTHER COUNTRIES
5.7 TECHNOLOGICAL ANALYSIS
5.8 KEY CONFERENCES & EVENTS, 2023–2024
TABLE 12 INSULIN DELIVERY DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
TABLE 13 AVERAGE SELLING PRICE OF INSULIN PENS, BY KEY PLAYER
TABLE 14 AVERAGE SELLING PRICE OF INSULIN PUMPS, BY KEY PLAYER
5.10 PATENT ANALYSIS
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2011–MAY 2023)
5.10.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 28 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTES) FOR INSULIN DELIVERY DEVICES PATENTS (JANUARY 2011–MAY 2023)
FIGURE 29 TOP APPLICANT COUNTRIES/REGIONS FOR INSULIN DELIVERY DEVICES (JANUARY 2011–MAY 2023)
5.11 VALUE CHAIN ANALYSIS
FIGURE 30 INSULIN DELIVERY DEVICES MARKET: VALUE CHAIN ANALYSIS
5.12 ECOSYSTEM MARKET MAP
FIGURE 31 INSULIN DELIVERY DEVICE MARKET: ECOSYSTEM MAPPING
5.13 USE CASES
TABLE 15 T:SLIM X2 INSULIN PUMPS TO OFFER CONTINUED IMPROVEMENTS IN FUNCTIONALITY, SAFETY, AND WEARABILITY OF PUMPS
TABLE 16 AUTOMATED AND SMART INSULIN DELIVERY DEVICE FOR DIABETES CARE
TABLE 17 CONTRIBUTION OF SMART INSULIN PEN IN LIGHTENING DIABETES MANAGEMENT LOAD
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INSULIN DELIVERY DEVICES
5.14.2 BUYING CRITERIA FOR INSULIN DELIVERY DEVICES
FIGURE 33 KEY BUYING CRITERIA FOR END USERS
6 INSULIN DELIVERY DEVICES MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 18 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 19 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (THOUSAND UNITS)
6.2 INSULIN PENS
6.2.1 ADVANCED AND CONVENIENT SOLUTIONS FOR INSULIN ADMINISTRATION TO DRIVE MARKET
TABLE 20 INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 21 INSULIN PENS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 INSULIN PENS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2 REUSABLE INSULIN PENS
6.2.2.1 Technology innovations to boost growth
TABLE 23 REUSABLE INSULIN PENS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 DISPOSABLE INSULIN PENS
6.2.3.1 Shift toward eco-friendly environment to restrain growth of market during forecast period
TABLE 24 DISPOSABLE INSULIN PENS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 INSULIN PUMPS
6.3.1 NEWER AND MORE REFINED TECHNOLOGY TO DRIVE INSULIN PUMPS MARKET
TABLE 25 INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 26 INSULIN PUMPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 INSULIN PUMPS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.3.2 TETHERED INSULIN PUMPS
6.3.2.1 Increasing collaborations and partnerships between companies to develop integrated CGM systems to drive market
TABLE 28 TETHERED INSULIN PUMPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 TUBELESS INSULIN PUMPS
6.3.3.1 Use of artificial intelligence and technological advancements to boost market
TABLE 29 TUBELESS INSULIN PUMPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 INSULIN PEN NEEDLES
TABLE 30 INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 31 INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 INSULIN PEN NEEDLES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.4.1 STANDARD INSULIN PEN NEEDLES
6.4.1.1 Affordability of standard insulin pen needles over safety pen needles to propel growth
TABLE 33 STANDARD INSULIN PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 34 STANDARD INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.2 SAFETY INSULIN PEN NEEDLES
6.4.2.1 Reducing chances of infection and accidental pricking to drive market
TABLE 35 SAFETY INSULIN PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 36 SAFETY INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 INSULIN SYRINGES
6.5.1 SAFETY CONCERNS AND INCREASING AWARENESS OF AFFORDABLE ALTERNATIVES TO RESTRAIN GROWTH
TABLE 37 INSULIN SYRINGES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 38 INSULIN SYRINGES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.6 OTHER INSULIN DELIVERY DEVICES
TABLE 39 OTHER INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 OTHER INSULIN DELIVERY DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
7 INSULIN DELIVERY DEVICES MARKET, BY END USER
7.1 INTRODUCTION
TABLE 41 INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
7.2 PATIENTS/HOME CARE
7.2.1 INCREASING AFFORDABILITY OF SELF-MONITORING SYSTEMS AND INSULIN DELIVERY DEVICES TO FUEL GROWTH
TABLE 42 INSULIN DELIVERY DEVICES MARKET FOR PATIENTS/HOME CARE, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 HOSPITALS & CLINICS
7.3.1 RISING DEMAND FOR POINT-OF-CARE TESTING IN HOSPITALS TO BOOST MARKET
TABLE 43 INSULIN DELIVERY DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
8 INSULIN DELIVERY DEVICES MARKET, BY REGION
8.1 INTRODUCTION
FIGURE 34 INSULIN DELIVERY DEVICES MARKET: GEOGRAPHIC SNAPSHOT
TABLE 44 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 35 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SNAPSHOT
TABLE 45 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 47 NORTH AMERICA: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 49 NORTH AMERICA: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 50 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2.2 US
8.2.2.1 Rising prevalence of diabetes and favorable reimbursement scenario to drive market
8.2.2.2 Growing venture capital investments and issuance of IPOs to propel market growth
TABLE 51 US: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 52 US: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 53 US: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 54 US: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 55 US: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2.3 CANADA
8.2.3.1 High prevalence of diabetes and favorable reimbursement for insulin delivery devices to boost market
TABLE 56 CANADA: ELIGIBILITY FOR INSULIN PUMPS AND SUPPLIES FOR TYPE I DIABETES, APRIL 2021
8.2.3.2 Regulations for usage of safety-engineered needles to drive market
TABLE 57 CANADA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 58 CANADA: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 59 CANADA: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 60 CANADA: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 61 CANADA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.3 EUROPE
8.3.1 EUROPE: RECESSION IMPACT
8.3.1.1 EU’s directive on prevention of sharps injuries in hospitals and healthcare sector to drive market
TABLE 62 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 64 EUROPE: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 65 EUROPE: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 67 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.3.2 GERMANY
8.3.2.1 High prevalence of diabetes and favorable reimbursement for insulin devices to propel market
TABLE 68 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 69 GERMANY: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 70 GERMANY: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 71 GERMANY: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 72 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.3.3 UK
8.3.3.1 Role of Diabetes UK in research and diabetes care to boost market
8.3.3.2 Insulin pump penetration to boost market
TABLE 73 UK: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 74 UK: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 75 UK: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 76 UK: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 77 UK: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.3.4 FRANCE
8.3.4.1 High insurance coverage and increasing affordability to drive market
TABLE 78 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 79 FRANCE: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 80 FRANCE: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 81 FRANCE: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 82 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.3.5 ITALY
8.3.5.1 Regional variations in terms of coverage and benefits to hinder market growth
TABLE 83 ITALY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 84 ITALY: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 85 ITALY: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 86 ITALY: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 87 ITALY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.3.6 SPAIN
8.3.6.1 Regulations for mandatory use of safety needles and increase in diabetic population to propel market
TABLE 88 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 89 SPAIN: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 90 SPAIN: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 91 SPAIN: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 92 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.3.7 REST OF EUROPE
8.3.7.1 Strong presence of major insulin delivery device manufacturers to drive market
TABLE 93 INDICATIVE LIST OF COMPANIES HEADQUARTERED IN REST OF EUROPE
FIGURE 36 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20–79 YEARS) IN MILLIONS
TABLE 94 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 95 REST OF EUROPE: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 96 REST OF EUROPE: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 97 REST OF EUROPE: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 98 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 37 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET SNAPSHOT
8.4.1.1 High diabetes incidence and population in Asia Pacific to boost market
TABLE 99 ASIA PACIFIC: DIABETES PREVALENCE, BY COUNTRY
8.4.1.2 Partnerships among global and local players in Asia Pacific to drive market
TABLE 100 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 102 ASIA PACIFIC: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 103 ASIA PACIFIC: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 ASIA PACIFIC: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.4.2 JAPAN
8.4.2.1 High adoption of insulin pens and approval of injectable insulin to propel growth
TABLE 106 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 107 JAPAN: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 108 JAPAN: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 109 JAPAN: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 110 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.4.3 CHINA
8.4.3.1 Sharp increase in diabetes in past decade and government support to drive market
TABLE 111 CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 112 CHINA: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 CHINA: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 114 CHINA: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 115 CHINA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.4.4 INDIA
8.4.4.1 Government initiatives to promote domestic manufacture of medical devices to drive market
TABLE 116 INDIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 117 INDIA: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 118 INDIA: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 119 INDIA: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 INDIA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.4.5 REST OF ASIA PACIFIC
8.4.5.1 Vietnam: Large diabetic population to boost market
8.4.5.2 Australia: Government initiatives to broaden patient access to diabetes products
TABLE 121 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 122 ASIA PACIFIC: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 123 ASIA PACIFIC: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 124 ASIA PACIFIC: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 125 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.5 REST OF THE WORLD
8.5.1 REST OF THE WORLD: RECESSION IMPACT
8.5.1.1 Increasing diabetic population to propel market
FIGURE 38 AFRICA: TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20–79 YEARS)
8.5.1.2 Favorable government policies and increasing prevalence of diabetic population to drive market
FIGURE 39 COUNT OF DIABETICS (20–79 YEARS) IN LATIN AMERICA REGION: TOP FIVE COUNTRIES
TABLE 126 REST OF THE WORLD: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 127 REST OF THE WORLD: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 128 REST OF THE WORLD: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 129 REST OF THE WORLD: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 130 REST OF THE WORLD: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
TABLE 131 INSULIN DELIVERY DEVICES MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
9.3 MARKET SHARE ANALYSIS
FIGURE 40 MARKET SHARE ANALYSIS FOR INSULIN PENS, BY KEY PLAYERS, 2022
FIGURE 41 MARKET SHARE ANALYSIS FOR INSULIN PUMPS, BY KEY PLAYERS, 2022
FIGURE 42 MARKET SHARE ANALYSIS FOR INSULIN PEN NEEDLES, BY KEY PLAYERS, 2022
FIGURE 43 MARKET SHARE ANALYSIS FOR INSULIN SYRINGES, BY KEY PLAYERS, 2022
9.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS (2020–2022)
9.5 MARKET RANKING ANALYSIS
FIGURE 45 INSULIN DELIVERY DEVICES MARKET RANKING, BY KEY PLAYERS, 2022
9.6 COMPANY EVALUATION QUADRANT: KEY PLAYERS
9.6.1 STARS
9.6.2 EMERGING LEADERS
9.6.3 PERVASIVE PLAYERS
9.6.4 PARTICIPANTS
FIGURE 46 INSULIN DELIVERY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (2022)
9.7 COMPANY EVALUATION QUADRANT: START-UPS & SMES
9.7.1 PROGRESSIVE COMPANIES
9.7.2 DYNAMIC COMPANIES
9.7.3 STARTING BLOCKS
9.7.4 RESPONSIVE COMPANIES
FIGURE 47 INSULIN DELIVERY DEVICES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS (2022)
9.8 COMPANY FOOTPRINT OF PLAYERS IN INSULIN DELIVERY DEVICES MARKET
TABLE 132 INSULIN DELIVERY DEVICES MARKET: COMPANY FOOTPRINT (2022)
9.8.1 TYPE FOOTPRINT
TABLE 133 INSULIN DELIVERY DEVICES MARKET: TYPE FOOTPRINT (2022)
9.8.2 REGIONAL FOOTPRINT
TABLE 134 INSULIN DELIVERY DEVICES MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS (2022)
9.9 COMPETITIVE SCENARIO
9.9.1 PRODUCT LAUNCHES
TABLE 135 PRODUCT LAUNCHES, JANUARY 2019–JUNE 2023
9.9.2 DEALS
TABLE 136 DEALS, JANUARY 2019–JUNE 2023
9.9.3 OTHER DEVELOPMENTS
TABLE 137 OTHER DEVELOPMENTS, JANUARY 2019–JUNE 2023
10 COMPANY PROFILES
10.1 KEY PLAYERS
(Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)*
10.1.1 EMBECTA CORP. (FORMERLY BECTON, DICKINSON AND COMPANY DIABETES CARE BUSINESS)
TABLE 138 EMBECTA CORP.: COMPANY OVERVIEW
FIGURE 48 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
10.1.2 NOVO NORDISK A/S
TABLE 139 NOVO NORDISK A/S: COMPANY OVERVIEW
FIGURE 49 NOVO NORDISK A/S: COMPANY SNAPSHOT (2022)
10.1.3 MEDTRONIC PLC
TABLE 140 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE 50 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
10.1.4 SANOFI
TABLE 141 SANOFI: COMPANY OVERVIEW
FIGURE 51 SANOFI: COMPANY SNAPSHOT (2022)
10.1.5 LILLY
TABLE 142 LILLY: COMPANY OVERVIEW
FIGURE 52 LILLY: COMPANY SNAPSHOT (2022)
10.1.6 YPSOMED HOLDING AG
TABLE 143 YPSOMED HOLDING AG: COMPANY OVERVIEW
FIGURE 53 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2023)
10.1.7 TANDEM DIABETES CARE, INC.
TABLE 144 TANDEM DIABETES CARE, INC.: COMPANY OVERVIEW
FIGURE 54 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT (2022)
10.1.8 INSULET CORPORATION
TABLE 145 INSULET CORPORATION: COMPANY OVERVIEW
FIGURE 55 INSULET CORPORATION: COMPANY SNAPSHOT (2022)
10.1.9 BIOCON LIMITED
TABLE 146 BIOCON LIMITED: COMPANY OVERVIEW
FIGURE 56 BIOCON LIMITED: COMPANY SNAPSHOT (2022)
10.1.10 ROCHE DIABETES CARE
TABLE 147 F. HOFFMANN-LA ROCHE: COMPANY OVERVIEW
FIGURE 57 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2022)
10.1.11 OWEN MUMFORD
TABLE 148 OWEN MUMFORD: COMPANY OVERVIEW
10.1.12 MEDTRUM TECHNOLOGIES INC.
TABLE 149 MEDTRUM TECHNOLOGIES INC.: COMPANY OVERVIEW
10.1.13 TERUMO CORPORATION
TABLE 150 TERUMO CORPORATION: COMPANY OVERVIEW
FIGURE 58 TERUMO CORPORATION: COMPANY SNAPSHOT (2021)
10.1.14 WOCKHARDT
TABLE 151 WOCKHARDT: COMPANY OVERVIEW
FIGURE 59 WOCKHARDT: COMPANY SNAPSHOT (2021)
*Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
10.2 OTHER PLAYERS
10.2.1 CEQUR CORPORATION
10.2.2 EOFLOW CO., LTD.
10.2.3 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD
10.2.4 SOOIL DEVELOPMENTS CO., LTD
10.2.5 SUNGSHIM MEDICAL CO., LTD.
10.2.6 VICENTRA B.V.
10.2.7 DEBIOTECH SA
10.2.8 JIANGSU DELFU MEDICAL DEVICE CO., LTD
10.2.9 HASELMEIER
10.2.10 MANNKIND CORPORATION
10.2.11 HTL-STREFA S.A.
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 CUSTOMIZATION OPTIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS 12.5.2 SOUTH AFRICA
12.5.2.1 Adoption of stricter emission norms and local manufacturing to drive market
TABLE 238 SOUTH AFRICA: PHEV POWERTRAIN MARKET, BY COMPONENT, 2018–2022 (USD MILLION)
TABLE 239 SOUTH AFRICA: PHEV POWERTRAIN MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
TABLE 240 SOUTH AFRICA: BEV POWERTRAIN MARKET, BY COMPONENT, 2018–2022 (USD MILLION)
TABLE 241 SOUTH AFRICA: BEV POWERTRAIN MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 ELECTRIC POWERTRAIN MARKET SHARE ANALYSIS, 2022
FIGURE 36 ELECTRIC POWERTRAIN MARKET SHARE ANALYSIS, 2022
FIGURE 37 REVENUE ANALYSIS OF TOP LISTED/PUBLIC PLAYERS: 2020–2022
13.3 COMPANY EVALUATION MATRIX: ELECTRIC POWERTRAIN MANUFACTURERS
13.3.1 STARS
13.3.2 EMERGING LEADERS
13.3.3 PERVASIVE PLAYERS
13.3.4 PARTICIPANTS
FIGURE 38 COMPETITIVE EVALUATION MATRIX (ELECTRIC POWERTRAIN MANUFACTURERS), 2022
TABLE 242 COMPANIES ADOPTED NEW PRODUCT DEVELOPMENTS AND EXPANSIONS AS KEY GROWTH STRATEGIES, 2022–2023
13.4 COMPETITIVE SCENARIO
13.4.1 NEW PRODUCT LAUNCHES
13.5 PRODUCT LAUNCHES
TABLE 243 PRODUCT LAUNCHES, 2021–2023
13.6 DEALS
TABLE 244 DEALS, 2021–2023
13.7 OTHERS
TABLE 245 OTHERS, 2022–2023
13.8 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2023
TABLE 246 KEY GROWTH STRATEGIES, 2022–2023
13.9 COMPETITIVE BENCHMARKING
TABLE 247 ELECTRIC POWERTRAIN MARKET: COMPETITIVE BENCHMARKING
13.10 LIST OF KEY START-UPS/SMES
TABLE 248 ELECTRIC POWERTRAIN MANUFACTURERS: LIST OF KEY START-UPS/SMES
14 COMPANY PROFILES
14.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 ROBERT BOSCH GMBH
TABLE 249 ROBERT BOSCH GMBH: COMPANY OVERVIEW
FIGURE 39 ROBERT BOSCH GMBH: COMPANY SNAPSHOT
TABLE 250 ROBERT BOSCH GMBH: PRODUCTS OFFERED
TABLE 251 ROBERT BOSCH GMBH: NEW PRODUCT DEVELOPMENTS
TABLE 252 ROBERT BOSCH GMBH: DEALS
TABLE 253 ROBERT BOSCH GMBH: OTHERS
14.1.2 MITSUBISHI ELECTRIC CORPORATION
TABLE 254 MITSUBISHI ELECTRIC CORPORATION: COMPANY OVERVIEW
FIGURE 40 MITSUBISHI ELECTRIC CORPORATION: COMPANY SNAPSHOT
TABLE 255 MITSUBISHI ELECTRIC CORPORATION: PRODUCTS OFFERED
TABLE 256 MITSUBISHI ELECTRIC CORPORATION: NEW PRODUCT DEVELOPMENTS
TABLE 257 MITSUBISHI ELECTRIC CORPORATION: DEALS
TABLE 258 MITSUBISHI ELECTRIC CORPORATION: OTHERS
14.1.3 MAGNA INTERNATIONAL INC.
TABLE 259 MAGNA INTERNATIONAL INC.: COMPANY OVERVIEW
FIGURE 41 MAGNA INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 260 MAGNA INTERNATIONAL INC.: PRODUCTS OFFERED
TABLE 261 MAGNA INTERNATIONAL INC.: NEW PRODUCT DEVELOPMENTS
TABLE 262 MAGNA INTERNATIONAL INC.: DEALS
TABLE 263 MAGNA INTERNATIONAL INC.: OTHERS
14.1.4 CONTINENTAL AG
TABLE 264 CONTINENTAL AG: COMPANY OVERVIEW
FIGURE 42 CONTINENTAL AG: COMPANY SNAPSHOT
TABLE 265 CONTINENTAL AG: PRODUCTS OFFERED
TABLE 266 CONTINENTAL AG: NEW PRODUCT DEVELOPMENTS
TABLE 267 CONTINENTAL AG: DEALS
TABLE 268 CONTINENTAL AG: OTHERS
14.1.5 HITACHI ASTEMO, LTD.
TABLE 269 HITACHI ASTEMO, LTD.: COMPANY OVERVIEW
FIGURE 43 HITACHI ASTEMO, LTD.: COMPANY SNAPSHOT
TABLE 270 HITACHI ASTEMO, LTD: PRODUCTS OFFERED
TABLE 271 HITACHI ASTEMO, LTD.: NEW PRODUCT DEVELOPMENTS
TABLE 272 HITACHI ASTEMO, LTD.: DEALS
TABLE 273 HITACHI ASTEMO, LTD.: OTHERS
14.1.6 BORGWARNER INC.
TABLE 274 BORGWARNER INC.: COMPANY OVERVIEW
FIGURE 44 BORGWARNER INC.: COMPANY SNAPSHOT
TABLE 275 BORGWARNER INC.: PRODUCTS OFFERED
TABLE 276 BORGWARNER INC.: NEW PRODUCT DEVELOPMENTS
TABLE 277 BORGWARNER INC.: DEALS
TABLE 278 BORGWARNER INC.: OTHERS
14.1.7 ZF FRIEDRICHSHAFEN AG
FIGURE 45 ZF FRIEDRICHSHAFEN AG: COMPANY SNAPSHOT
TABLE 279 ZF FRIEDRICHSHAFEN AG: PRODUCTS OFFERED
TABLE 280 ZF FRIEDRICHSHAFEN AG: NEW PRODUCT DEVELOPMENTS
TABLE 281 ZF FRIEDRICHSHAFEN AG: DEALS
TABLE 282 ZF FRIEDRICHSHAFEN AG: OTHERS
14.1.8 DENSO CORPORATION
TABLE 283 DENSO CORPORATION: COMPANY OVERVIEW
FIGURE 46 DENSO CORPORATION: COMPANY SNAPSHOT
TABLE 284 DENSO CORPORATION: PRODUCTS OFFERED
TABLE 285 DENSO CORPORATION: NEW PRODUCT DEVELOPMENTS
TABLE 286 DENSO CORPORATION: DEALS
TABLE 287 DENSO CORPORATION: OTHERS
14.1.9 DANA INCORPORATED
TABLE 288 DANA INCORPORATED: COMPANY OVERVIEW
FIGURE 47 DANA INCORPORATED: COMPANY SNAPSHOT
TABLE 289 DANA INCORPORATED: PRODUCTS OFFERED
TABLE 290 DANA INCORPORATED: NEW PRODUCT DEVELOPMENTS
TABLE 291 DANA INCORPORATED: DEALS
TABLE 292 DANA INCORPORATED: OTHERS
14.1.10 VALEO S.A.
TABLE 293 VALEO S.A.: COMPANY OVERVIEW
FIGURE 48 VALEO S.A.: COMPANY SNAPSHOT
TABLE 294 VALEO S.A.: PRODUCTS OFFERED
TABLE 295 VALEO S.A.: NEW PRODUCT DEVELOPMENTS
TABLE 296 VALEO S.A.: DEALS
14.2 OTHER PLAYERS
14.2.1 BRUSA ELEKTRONIK AG
TABLE 297 BRUSA ELEKTRONIK AG: COMPANY OVERVIEW
14.2.2 KELLY CONTROLS
TABLE 298 KELLY CONTROLS: COMPANY OVERVIEW
14.2.3 NIDEC CORPORATION
TABLE 299 NIDEC CORPORATION: COMPANY OVERVIEW
14.2.4 MAGNETI MARELLI CK HOLDINGS
TABLE 300 MAGNETI MARELLI CK HOLDINGS: COMPANY OVERVIEW
14.2.5 TOYOTA INDUSTRIES CORPORATION
TABLE 301 TOYOTA INDUSTRIES CORPORATION: COMPANY OVERVIEW
14.2.6 PANASONIC
TABLE 302 PANASONIC: COMPANY OVERVIEW
14.2.7 CURTIS INSTRUMENTS
TABLE 303 CURTIS INSTRUMENTS: COMPANY OVERVIEW
14.2.8 FILTRAN LLC
TABLE 304 FILTRAN LLC: COMPANY OVERVIEW
14.2.9 MAGTEC
TABLE 305 MAGTEC: COMPANY OVERVIEW
14.2.10 CASCADIA MOTION
TABLE 306 CASCADIA MOTION: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 COMPANY PROFILES: EV BATTERY MARKET
15.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
15.1.1 CATL
TABLE 307 CATL: BUSINESS OVERVIEW
FIGURE 49 CATL: COMPANY SNAPSHOT
TABLE 308 CATL: SUPPLY AGREEMENTS
TABLE 309 CATL: PRODUCTS OFFERED
TABLE 310 CATL: NEW PRODUCT DEVELOPMENTS
TABLE 311 CATL: DEALS
TABLE 312 CATL: OTHERS
15.1.2 SAMSUNG SDI
TABLE 313 SAMSUNG SDI: BUSINESS OVERVIEW
FIGURE 50 SAMSUNG SDI: COMPANY SNAPSHOT
TABLE 314 SAMSUNG SDI: SUPPLY AGREEMENTS
TABLE 315 SAMSUNG SDI: PRODUCTS OFFERED
TABLE 316 SAMSUNG SDI: NEW PRODUCT DEVELOPMENTS
TABLE 317 SAMSUNG SDI: DEALS
TABLE 318 SAMSUNG SDI: OTHERS
15.1.3 PANASONIC HOLDINGS CORPORATION
TABLE 319 PANASONIC HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 51 PANASONIC HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 320 PANASONIC HOLDINGS CORPORATION: SUPPLY AGREEMENTS
TABLE 321 PANASONIC HOLDINGS CORPORATION: PRODUCTS OFFERED
TABLE 322 PANASONIC HOLDINGS CORPORATION: NEW PRODUCT DEVELOPMENTS
TABLE 323 PANASONIC HOLDINGS CORPORATION: DEALS
TABLE 324 PANASONIC HOLDINGS CORPORATION: OTHERS
15.1.4 LG CHEM
TABLE 325 LG CHEM: BUSINESS OVERVIEW
TABLE 326 LG CHEM: R&D OVERVIEW
FIGURE 52 LG CHEM: COMPANY SNAPSHOT
TABLE 327 LG CHEM.: SUPPLY AGREEMENTS
TABLE 328 LG CHEM: PRODUCTS OFFERED
TABLE 329 LG CHEM: NEW PRODUCT DEVELOPMENTS
TABLE 330 LG CHEM: DEALS
TABLE 331 LG CHEM: OTHERS
15.1.5 BYD COMPANY LIMITED
TABLE 332 BYD COMPANY LIMITED: BUSINESS OVERVIEW
FIGURE 53 BYD COMPANY LIMITED: COMPANY SNAPSHOT
TABLE 333 BYD COMPANY LIMITED: PRODUCTS OFFERED
TABLE 334 BYD: NEW PRODUCT DEVELOPMENTS
TABLE 335 BYD: DEALS
TABLE 336 BYD: OTHERS
15.2 MID-TIER PLAYERS
15.2.1 SK INNOVATION CO. LTD.
TABLE 337 SK INNOVATION CO. LTD.: BUSINESS OVERVIEW
FIGURE 54 SK INNOVATION CO. LTD.: COMPANY SNAPSHOT
TABLE 338 SK INNOVATION CO. LTD.: SUPPLY AGREEMENTS
TABLE 339 SK INNOVATION CO. LTD.: PRODUCTS OFFERED
TABLE 340 SK INNOVATION CO. LTD.: NEW PRODUCT DEVELOPMENTS
TABLE 341 SK INNOVATION CO. LTD.: DEALS
TABLE 342 SK INNOVATION CO. LTD.: OTHERS
15.2.2 VEHICLE ENERGY JAPAN INC.
TABLE 343 VEHICLE ENERGY JAPAN INC.: BUSINESS OVERVIEW
TABLE 344 VEHICLE ENERGY JAPAN INC.: SUPPLY AGREEMENTS
TABLE 345 VEHICLE ENERGY JAPAN INC.: PRODUCTS OFFERED
TABLE 346 VEHICLE ENERGY JAPAN INC.: DEALS
TABLE 347 VEHICLE ENERGY JAPAN INC.: OTHERS
15.2.3 TOSHIBA CORPORATION
TABLE 348 TOSHIBA CORPORATION: BUSINESS OVERVIEW
TABLE 349 TOSHIBA CORPORATION: SUPPLY AGREEMENTS
TABLE 350 TOSHIBA CORPORATION: PRODUCTS OFFERED
TABLE 351 TOSHIBA CORPORATION: NEW PRODUCT DEVELOPMENTS
TABLE 352 TOSHIBA CORPORATION: DEALS
TABLE 353 TOSHIBA CORPORATION: OTHERS
15.2.4 MITSUBISHI CORPORATION
TABLE 354 MITSUBISHI CORPORATION: BUSINESS OVERVIEW
TABLE 355 MITSUBISHI CORPORATION: PRODUCTS OFFERED
TABLE 356 MITSUBISHI CORPORATION: NEW PRODUCT DEVELOPMENT
TABLE 357 MITSUBISHI CORPORATION: DEALS
TABLE 358 MITSUBISHI CORPORATION: OTHERS
15.2.5 ENERSYS
TABLE 359 ENERSYS: BUSINESS OVERVIEW
TABLE 360 ENERSYS: PRODUCTS OFFERED
TABLE 361 ENERSYS: NEW PRODUCT DEVELOPMENTS
TABLE 362 ENERSYS: DEALS
15.3 START-UPS
15.3.1 NORTHVOLT AB
TABLE 363 NORTHVOLT AB: BUSINESS OVERVIEW
15.3.2 AUTOMOTIVE CELLS COMPANY
TABLE 364 AUTOMOTIVE CELL COMPANY: BUSINESS OVERVIEW
15.3.3 BLUEOVAL SK
TABLE 365 BLUEOVAL SK: BUSINESS OVERVIEW
15.3.4 CELLFORCE GROUP GMBH
TABLE 366 CELLFORCE GROUP GMBH: BUSINESS OVERVIEW
15.3.5 GOTION HI-TECH
TABLE 367 GOTION HI-TECH: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
16 COMPANY PROFILES: AUTOMOTIVE TRACTION MOTOR MARKET
16.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
16.1.1 BORGWARNER INC.
TABLE 368 BORGWARNER INC.: BUSINESS OVERVIEW
FIGURE 55 BORGWARNER INC.: COMPANY SNAPSHOT
TABLE 369 BORGWARNER INC.: SUPPLY AGREEMENTS
TABLE 370 BORGWARNER INC.: PRODUCTS OFFERED
TABLE 371 BORGWARNER INC.: NEW PRODUCT DEVELOPMENTS
TABLE 372 BORGWARNER INC.: DEALS
TABLE 373 BORGWARNER INC.: OTHERS
16.1.2 BYD CO., LTD.
TABLE 374 BYD CO., LTD.: BUSINESS OVERVIEW
FIGURE 56 BYD CO., LTD.: COMPANY SNAPSHOT
TABLE 375 BYD CO., LTD.: SUPPLY AGREEMENTS
TABLE 376 BYD CO., LTD.: PRODUCTS OFFERED
TABLE 377 BYD CO., LTD.: NEW PRODUCT DEVELOPMENTS
TABLE 378 BYD CO., LTD.: DEALS
TABLE 379 BYD CO., LTD.: OTHERS
16.1.3 SCHAEFFLER GROUP
TABLE 380 SCHAEFFLER GROUP: BUSINESS OVERVIEW
FIGURE 57 SCHAEFFLER GROUP: COMPANY SNAPSHOT
TABLE 381 SCHAEFFLER GROUP: SUPPLY AGREEMENTS
TABLE 382 SCHAEFFLER GROUP: PRODUCTS OFFERED
TABLE 383 SCHAEFFLER GROUP: NEW PRODUCT DEVELOPMENTS
TABLE 384 SCHAEFFLER GROUP: DEALS
TABLE 385 SCHAEFFLER GROUP: OTHERS
16.1.4 ROBERT BOSCH GMBH
TABLE 386 ROBERT BOSCH GMBH: BUSINESS OVERVIEW
FIGURE 58 ROBERT BOSCH GMBH: COMPANY SNAPSHOT
TABLE 387 ROBERT BOSCH GMBH: SUPPLY AGREEMENTS
TABLE 388 ROBERT BOSCH GMBH: PRODUCTS OFFERED
TABLE 389 ROBERT BOSCH GMBH: NEW PRODUCT DEVELOPMENTS
TABLE 390 ROBERT BOSCH GMBH: DEALS
TABLE 391 ROBERT BOSCH GMBH: OTHERS
16.1.5 ZF FRIEDRICHSHAFEN AG
TABLE 392 ZF FRIEDRICHSHAFEN AG: BUSINESS OVERVIEW
FIGURE 59 ZF FRIEDRICHSHAFEN AG: COMPANY SNAPSHOT
TABLE 393 ZF FRIEDRICHSHAFEN AG: SUPPLY AGREEMENTS
TABLE 394 ZF FRIEDRICHSHAFEN AG: PRODUCTS OFFERED
TABLE 395 ZF FRIEDRICHSHAFEN AG: NEW PRODUCT DEVELOPMENTS
TABLE 396 ZF FRIEDRICHSHAFEN AG: DEALS
TABLE 397 ZF FRIEDRICHSHAFEN AG: OTHERS
16.2 MID-TIER PLAYERS
16.2.1 JOHNSON ELECTRIC HOLDINGS LTD.
TABLE 398 JOHNSON ELECTRIC HOLDINGS LTD.: BUSINESS OVERVIEW
FIGURE 60 JOHNSON ELECTRIC HOLDINGS LTD.: COMPANY SNAPSHOT
TABLE 399 JOHNSON ELECTRIC HOLDINGS LTD.: PRODUCTS OFFERED
TABLE 400 JOHNSON ELECTRIC: OTHER DEVELOPMENTS
16.2.2 CONTINENTAL AG
TABLE 401 CONTINENTAL AG: BUSINESS OVERVIEW
FIGURE 61 CONTINENTAL AG: COMPANY SNAPSHOT
TABLE 402 CONTINENTAL AG: SUPPLY AGREEMENTS
TABLE 403 CONTINENTAL AG: PRODUCTS OFFERED
TABLE 404 CONTINENTAL AG: NEW PRODUCT DEVELOPMENTS
TABLE 405 CONTINENTAL AG: OTHERS
16.2.3 VALEO S.A.
TABLE 406 VALEO S.A.: BUSINESS OVERVIEW
FIGURE 62 VALEO S.A.: COMPANY SNAPSHOT
TABLE 407 VALEO S.A.: SUPPLY AGREEMENTS
TABLE 408 VALEO S.A.: PRODUCTS OFFERED
TABLE 409 VALEO S.A.: NEW PRODUCT DEVELOPMENT
TABLE 410 VALEO S.A.: DEALS
16.2.4 MAHLE GROUP
TABLE 411 MAHLE GROUP: BUSINESS OVERVIEW
FIGURE 63 MAHLE GROUP: COMPANY SNAPSHOT
TABLE 412 MAHLE GROUP: PRODUCTS OFFERED
TABLE 413 MAHLE GROUP: NEW PRODUCT DEVELOPMENT
TABLE 414 MAHLE GROUP: DEALS
TABLE 415 MAHLE GROUP: OTHERS
16.2.5 NIDEC CORPORATION
TABLE 416 NIDEC CORPORATION: BUSINESS OVERVIEW
FIGURE 64 NIDEC CORPORATION: COMPANY SNAPSHOT
TABLE 417 NIDEC CORPORATION: SUPPLY AGREEMENTS
TABLE 418 NIDEC CORPORATION: PRODUCTS OFFERED
TABLE 419 NIDEC CORPORATION: NEW PRODUCT DEVELOPMENTS
TABLE 420 NIDEC CORPORATION: DEALS
TABLE 421 NIDEC CORPORATION: OTHERS
16.3 OTHER PLAYERS
16.3.1 JING-JIN ELECTRIC
TABLE 422 JING-JIN ELECTRIC: BUSINESS OVERVIEW
16.3.2 SHANGHAI EDRIVE CO., LTD.
TABLE 423 SHANGHAI EDRIVE CO., LTD.: BUSINESS OVERVIEW
16.3.3 XPT WEILAI DRIVE TECHNOLOGY
TABLE 424 XPT WEILAI DRIVE TECHNOLOGY: BUSINESS OVERVIEW
16.3.4 ZHUHAI ENPOWER ELECTRIC CO., LTD.
TABLE 425 ZHUHAI ENPOWER ELECTRIC CO., LTD.: BUSINESS OVERVIEW
16.3.5 ANAND MANDO EMOBILITY
TABLE 426 ANAND MANDO EMOBILITY: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
17 RECOMMENDATIONS BY MARKETS AND MARKETS
17.1 ASIA PACIFIC TO BE MAJOR MARKET FOR ELECTRIC POWERTRAINS
17.2 BEV POWERTRAIN COMPONENTS CAN BE KEY FOCUS FOR MANUFACTURERS
17.3 CONCLUSION
18 APPENDIX
18.1 KEY INDUSTRY INSIGHTS
18.2 DISCUSSION GUIDE
18.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.4 CUSTOMIZATION OPTIONS
18.4.1 ELECTRIC POWERTRAIN MARKET, BY VEHICLE TYPE
18.4.1.1 BEV
18.4.1.2 HEV/PHEV
18.4.1.3 FCEV
18.4.2 ELECTRIC POWERTRAIN MARKET, BY TYPE
18.4.2.1 BEV powertrain
18.4.2.2 Series hybrid powertrain
18.4.2.3 Parallel hybrid powertrain
18.4.2.4 Series-parallel hybrid powertrain
18.5 RELATED REPORTS
18.6 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 INSULIN DELIVERY DEVICES MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2022)
FIGURE 6 MARKET SIZE ESTIMATION: COMPANY-WISE REVENUE SHARE ANALYSIS (2022)
FIGURE 7 INSULIN DELIVERY DEVICES MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF INSULIN DELIVERY DEVICES MARKET
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 IMPACT OF RECESSION
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS. 2021–2027 (%GROWTH)
3 EXECUTIVE SUMMARY
FIGURE 10 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 INSULIN DELIVERY DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF INSULIN DELIVERY DEVICES MARKET
4 PREMIUM INSIGHTS
4.1 INSULIN DELIVERY DEVICES: MARKET OVERVIEW
FIGURE 13 INCREASING TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY DEVICES TO DRIVE MARKET
4.2 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE AND COUNTRY (2022)
FIGURE 14 INSULIN PENS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
4.3 INSULIN DELIVERY DEVICES MARKET: GEOGRAPHICAL MIX
FIGURE 15 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.4 INSULIN DELIVERY DEVICES MARKET: REGIONAL MIX (2023–2028)
FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD (2023–2028)
4.5 INSULIN DELIVERY DEVICES MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 17 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 INSULIN DELIVERY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of diabetic population
FIGURE 19 GLOBAL PREVALENCE OF DIABETES IN INDIVIDUALS AGED 20–79 YEARS, 2015–2021 (MILLIONS)
FIGURE 20 PROJECTION OF DIABETES FOR INDIVIDUALS AGED 20–79 YEARS, 2030-2045 (MILLIONS)
FIGURE 21 TOP TEN COUNTRIES WITH HIGHEST COUNT OF DIABETICS (20–79 YEARS), 2021 & 2045
5.2.1.2 Technological advancements in insulin delivery devices
FIGURE 22 ADVANCEMENTS IN INSULIN DELIVERY DEVICES
5.2.1.3 Government support and favorable reimbursement schemes to favor market growth
5.2.2 RESTRAINTS
5.2.2.1 High costs and lack of reimbursement in developing countries
5.2.2.2 Needle anxiety in patients to affect growth of pen needles and syringes market
5.2.2.3 Oral insulin as alternative drug delivery method
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing R&D activities and strategic partnerships
5.2.3.2 Increasing healthcare expenditure on diabetes care
FIGURE 23 TOTAL HEALTH EXPENDITURE ON DIABETES CARE, 2021–2045 (USD BILLION)
5.2.3.3 Advances in syringe and needle technology
5.2.3.4 Mandates pertaining to safety-engineered medical needles to encourage market growth
5.2.4 CHALLENGES
5.2.4.1 Needlestick injuries and misuse of injection pens
5.2.4.2 Lack of interoperability among insulin delivery devices
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 INSULIN DELIVERY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 INTENSITY OF COMPETITIVE RIVALRY
5.3.2 BARGAINING POWER OF SUPPLIERS
5.3.3 BARGAINING POWER OF BUYERS
5.3.4 THREAT OF SUBSTITUTES
5.3.5 THREAT OF NEW ENTRANTS
5.4 REGULATORY ANALYSIS
TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES
5.4.1 NORTH AMERICA
5.4.1.1 US
TABLE 4 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
FIGURE 24 FDA 510(K) APPROVAL PROCESS
5.4.1.2 Canada
5.4.2 EUROPE
FIGURE 25 CE MARK APPROVAL PROCESS FOR INSULIN DELIVERY DEVICES
5.4.3 ASIA PACIFIC
5.4.3.1 Japan
TABLE 5 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY
5.4.3.2 China
TABLE 6 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.3.3 India
TABLE 7 INDIA: MEDICAL DEVICE CLASSIFICATION
5.4.3.4 Australia
FIGURE 26 SUMMARY OF APPROVAL, ACCESS, AND DISTRIBUTION PATHWAYS FOR NEW TECHNOLOGY USED FOR INSULIN DRUG DELIVERY DEVICES
5.4.4 REST OF THE WORLD
5.5 INDUSTRY INSIGHTS
5.5.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS
TABLE 8 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO
5.5.2 SYNCHRONIZATION OF SMART INSULIN PENS WITH CGM SYSTEMS TO PROMOTE DIABETES DATA SHARING
TABLE 9 MAJOR SMART INSULIN PENS AVAILABLE GLOBALLY
5.5.3 INCREASING NUMBER OF COLLABORATIONS AMONG STAKEHOLDERS
TABLE 10 INSULIN DELIVERY DEVICE MARKET: RECENT COLLABORATIONS
5.6 REIMBURSEMENT SCENARIO
TABLE 11 INSULIN DELIVERY DEVICES: GLOBAL COVERAGE AND REIMBURSEMENT
5.6.1 US
5.6.2 CANADA
5.6.3 UK
5.6.4 AUSTRALIA
5.6.5 OTHER COUNTRIES
5.7 TECHNOLOGICAL ANALYSIS
5.8 KEY CONFERENCES & EVENTS, 2023–2024
TABLE 12 INSULIN DELIVERY DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
TABLE 13 AVERAGE SELLING PRICE OF INSULIN PENS, BY KEY PLAYER
TABLE 14 AVERAGE SELLING PRICE OF INSULIN PUMPS, BY KEY PLAYER
5.10 PATENT ANALYSIS
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2011–MAY 2023)
5.10.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 28 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTES) FOR INSULIN DELIVERY DEVICES PATENTS (JANUARY 2011–MAY 2023)
FIGURE 29 TOP APPLICANT COUNTRIES/REGIONS FOR INSULIN DELIVERY DEVICES (JANUARY 2011–MAY 2023)
5.11 VALUE CHAIN ANALYSIS
FIGURE 30 INSULIN DELIVERY DEVICES MARKET: VALUE CHAIN ANALYSIS
5.12 ECOSYSTEM MARKET MAP
FIGURE 31 INSULIN DELIVERY DEVICE MARKET: ECOSYSTEM MAPPING
5.13 USE CASES
TABLE 15 T:SLIM X2 INSULIN PUMPS TO OFFER CONTINUED IMPROVEMENTS IN FUNCTIONALITY, SAFETY, AND WEARABILITY OF PUMPS
TABLE 16 AUTOMATED AND SMART INSULIN DELIVERY DEVICE FOR DIABETES CARE
TABLE 17 CONTRIBUTION OF SMART INSULIN PEN IN LIGHTENING DIABETES MANAGEMENT LOAD
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INSULIN DELIVERY DEVICES
5.14.2 BUYING CRITERIA FOR INSULIN DELIVERY DEVICES
FIGURE 33 KEY BUYING CRITERIA FOR END USERS
6 INSULIN DELIVERY DEVICES MARKET, BY TYPE
6.1 INTRODUCTION
TABLE 18 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 19 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (THOUSAND UNITS)
6.2 INSULIN PENS
6.2.1 ADVANCED AND CONVENIENT SOLUTIONS FOR INSULIN ADMINISTRATION TO DRIVE MARKET
TABLE 20 INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 21 INSULIN PENS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 22 INSULIN PENS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.2.2 REUSABLE INSULIN PENS
6.2.2.1 Technology innovations to boost growth
TABLE 23 REUSABLE INSULIN PENS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 DISPOSABLE INSULIN PENS
6.2.3.1 Shift toward eco-friendly environment to restrain growth of market during forecast period
TABLE 24 DISPOSABLE INSULIN PENS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 INSULIN PUMPS
6.3.1 NEWER AND MORE REFINED TECHNOLOGY TO DRIVE INSULIN PUMPS MARKET
TABLE 25 INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 26 INSULIN PUMPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 27 INSULIN PUMPS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.3.2 TETHERED INSULIN PUMPS
6.3.2.1 Increasing collaborations and partnerships between companies to develop integrated CGM systems to drive market
TABLE 28 TETHERED INSULIN PUMPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 TUBELESS INSULIN PUMPS
6.3.3.1 Use of artificial intelligence and technological advancements to boost market
TABLE 29 TUBELESS INSULIN PUMPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 INSULIN PEN NEEDLES
TABLE 30 INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 31 INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 32 INSULIN PEN NEEDLES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.4.1 STANDARD INSULIN PEN NEEDLES
6.4.1.1 Affordability of standard insulin pen needles over safety pen needles to propel growth
TABLE 33 STANDARD INSULIN PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 34 STANDARD INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.4.2 SAFETY INSULIN PEN NEEDLES
6.4.2.1 Reducing chances of infection and accidental pricking to drive market
TABLE 35 SAFETY INSULIN PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 36 SAFETY INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.5 INSULIN SYRINGES
6.5.1 SAFETY CONCERNS AND INCREASING AWARENESS OF AFFORDABLE ALTERNATIVES TO RESTRAIN GROWTH
TABLE 37 INSULIN SYRINGES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 38 INSULIN SYRINGES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
6.6 OTHER INSULIN DELIVERY DEVICES
TABLE 39 OTHER INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 OTHER INSULIN DELIVERY DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)
7 INSULIN DELIVERY DEVICES MARKET, BY END USER
7.1 INTRODUCTION
TABLE 41 INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
7.2 PATIENTS/HOME CARE
7.2.1 INCREASING AFFORDABILITY OF SELF-MONITORING SYSTEMS AND INSULIN DELIVERY DEVICES TO FUEL GROWTH
TABLE 42 INSULIN DELIVERY DEVICES MARKET FOR PATIENTS/HOME CARE, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 HOSPITALS & CLINICS
7.3.1 RISING DEMAND FOR POINT-OF-CARE TESTING IN HOSPITALS TO BOOST MARKET
TABLE 43 INSULIN DELIVERY DEVICES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)
8 INSULIN DELIVERY DEVICES MARKET, BY REGION
8.1 INTRODUCTION
FIGURE 34 INSULIN DELIVERY DEVICES MARKET: GEOGRAPHIC SNAPSHOT
TABLE 44 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 35 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SNAPSHOT
TABLE 45 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 47 NORTH AMERICA: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 49 NORTH AMERICA: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 50 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2.2 US
8.2.2.1 Rising prevalence of diabetes and favorable reimbursement scenario to drive market
8.2.2.2 Growing venture capital investments and issuance of IPOs to propel market growth
TABLE 51 US: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 52 US: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 53 US: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 54 US: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 55 US: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2.3 CANADA
8.2.3.1 High prevalence of diabetes and favorable reimbursement for insulin delivery devices to boost market
TABLE 56 CANADA: ELIGIBILITY FOR INSULIN PUMPS AND SUPPLIES FOR TYPE I DIABETES, APRIL 2021
8.2.3.2 Regulations for usage of safety-engineered needles to drive market
TABLE 57 CANADA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 58 CANADA: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 59 CANADA: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 60 CANADA: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 61 CANADA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.3 EUROPE
8.3.1 EUROPE: RECESSION IMPACT
8.3.1.1 EU’s directive on prevention of sharps injuries in hospitals and healthcare sector to drive market
TABLE 62 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 64 EUROPE: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 65 EUROPE: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 67 EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.3.2 GERMANY
8.3.2.1 High prevalence of diabetes and favorable reimbursement for insulin devices to propel market
TABLE 68 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 69 GERMANY: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 70 GERMANY: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 71 GERMANY: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 72 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.3.3 UK
8.3.3.1 Role of Diabetes UK in research and diabetes care to boost market
8.3.3.2 Insulin pump penetration to boost market
TABLE 73 UK: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 74 UK: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 75 UK: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 76 UK: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 77 UK: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.3.4 FRANCE
8.3.4.1 High insurance coverage and increasing affordability to drive market
TABLE 78 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 79 FRANCE: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 80 FRANCE: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 81 FRANCE: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 82 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.3.5 ITALY
8.3.5.1 Regional variations in terms of coverage and benefits to hinder market growth
TABLE 83 ITALY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 84 ITALY: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 85 ITALY: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 86 ITALY: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 87 ITALY: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.3.6 SPAIN
8.3.6.1 Regulations for mandatory use of safety needles and increase in diabetic population to propel market
TABLE 88 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 89 SPAIN: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 90 SPAIN: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 91 SPAIN: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 92 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.3.7 REST OF EUROPE
8.3.7.1 Strong presence of major insulin delivery device manufacturers to drive market
TABLE 93 INDICATIVE LIST OF COMPANIES HEADQUARTERED IN REST OF EUROPE
FIGURE 36 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20–79 YEARS) IN MILLIONS
TABLE 94 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 95 REST OF EUROPE: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 96 REST OF EUROPE: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 97 REST OF EUROPE: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 98 REST OF EUROPE: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 37 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET SNAPSHOT
8.4.1.1 High diabetes incidence and population in Asia Pacific to boost market
TABLE 99 ASIA PACIFIC: DIABETES PREVALENCE, BY COUNTRY
8.4.1.2 Partnerships among global and local players in Asia Pacific to drive market
TABLE 100 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 101 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 102 ASIA PACIFIC: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 103 ASIA PACIFIC: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 ASIA PACIFIC: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.4.2 JAPAN
8.4.2.1 High adoption of insulin pens and approval of injectable insulin to propel growth
TABLE 106 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 107 JAPAN: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 108 JAPAN: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 109 JAPAN: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 110 JAPAN: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.4.3 CHINA
8.4.3.1 Sharp increase in diabetes in past decade and government support to drive market
TABLE 111 CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 112 CHINA: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 CHINA: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 114 CHINA: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 115 CHINA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.4.4 INDIA
8.4.4.1 Government initiatives to promote domestic manufacture of medical devices to drive market
TABLE 116 INDIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 117 INDIA: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 118 INDIA: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 119 INDIA: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 INDIA: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.4.5 REST OF ASIA PACIFIC
8.4.5.1 Vietnam: Large diabetic population to boost market
8.4.5.2 Australia: Government initiatives to broaden patient access to diabetes products
TABLE 121 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 122 ASIA PACIFIC: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 123 ASIA PACIFIC: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 124 ASIA PACIFIC: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 125 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
8.5 REST OF THE WORLD
8.5.1 REST OF THE WORLD: RECESSION IMPACT
8.5.1.1 Increasing diabetic population to propel market
FIGURE 38 AFRICA: TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20–79 YEARS)
8.5.1.2 Favorable government policies and increasing prevalence of diabetic population to drive market
FIGURE 39 COUNT OF DIABETICS (20–79 YEARS) IN LATIN AMERICA REGION: TOP FIVE COUNTRIES
TABLE 126 REST OF THE WORLD: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 127 REST OF THE WORLD: INSULIN PENS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 128 REST OF THE WORLD: INSULIN PUMPS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 129 REST OF THE WORLD: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 130 REST OF THE WORLD: INSULIN DELIVERY DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
TABLE 131 INSULIN DELIVERY DEVICES MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
9.3 MARKET SHARE ANALYSIS
FIGURE 40 MARKET SHARE ANALYSIS FOR INSULIN PENS, BY KEY PLAYERS, 2022
FIGURE 41 MARKET SHARE ANALYSIS FOR INSULIN PUMPS, BY KEY PLAYERS, 2022
FIGURE 42 MARKET SHARE ANALYSIS FOR INSULIN PEN NEEDLES, BY KEY PLAYERS, 2022
FIGURE 43 MARKET SHARE ANALYSIS FOR INSULIN SYRINGES, BY KEY PLAYERS, 2022
9.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS (2020–2022)
9.5 MARKET RANKING ANALYSIS
FIGURE 45 INSULIN DELIVERY DEVICES MARKET RANKING, BY KEY PLAYERS, 2022
9.6 COMPANY EVALUATION QUADRANT: KEY PLAYERS
9.6.1 STARS
9.6.2 EMERGING LEADERS
9.6.3 PERVASIVE PLAYERS
9.6.4 PARTICIPANTS
FIGURE 46 INSULIN DELIVERY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING (2022)
9.7 COMPANY EVALUATION QUADRANT: START-UPS & SMES
9.7.1 PROGRESSIVE COMPANIES
9.7.2 DYNAMIC COMPANIES
9.7.3 STARTING BLOCKS
9.7.4 RESPONSIVE COMPANIES
FIGURE 47 INSULIN DELIVERY DEVICES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS (2022)
9.8 COMPANY FOOTPRINT OF PLAYERS IN INSULIN DELIVERY DEVICES MARKET
TABLE 132 INSULIN DELIVERY DEVICES MARKET: COMPANY FOOTPRINT (2022)
9.8.1 TYPE FOOTPRINT
TABLE 133 INSULIN DELIVERY DEVICES MARKET: TYPE FOOTPRINT (2022)
9.8.2 REGIONAL FOOTPRINT
TABLE 134 INSULIN DELIVERY DEVICES MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS (2022)
9.9 COMPETITIVE SCENARIO
9.9.1 PRODUCT LAUNCHES
TABLE 135 PRODUCT LAUNCHES, JANUARY 2019–JUNE 2023
9.9.2 DEALS
TABLE 136 DEALS, JANUARY 2019–JUNE 2023
9.9.3 OTHER DEVELOPMENTS
TABLE 137 OTHER DEVELOPMENTS, JANUARY 2019–JUNE 2023
10 COMPANY PROFILES
10.1 KEY PLAYERS
(Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)*
10.1.1 EMBECTA CORP. (FORMERLY BECTON, DICKINSON AND COMPANY DIABETES CARE BUSINESS)
TABLE 138 EMBECTA CORP.: COMPANY OVERVIEW
FIGURE 48 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
10.1.2 NOVO NORDISK A/S
TABLE 139 NOVO NORDISK A/S: COMPANY OVERVIEW
FIGURE 49 NOVO NORDISK A/S: COMPANY SNAPSHOT (2022)
10.1.3 MEDTRONIC PLC
TABLE 140 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE 50 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
10.1.4 SANOFI
TABLE 141 SANOFI: COMPANY OVERVIEW
FIGURE 51 SANOFI: COMPANY SNAPSHOT (2022)
10.1.5 LILLY
TABLE 142 LILLY: COMPANY OVERVIEW
FIGURE 52 LILLY: COMPANY SNAPSHOT (2022)
10.1.6 YPSOMED HOLDING AG
TABLE 143 YPSOMED HOLDING AG: COMPANY OVERVIEW
FIGURE 53 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2023)
10.1.7 TANDEM DIABETES CARE, INC.
TABLE 144 TANDEM DIABETES CARE, INC.: COMPANY OVERVIEW
FIGURE 54 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT (2022)
10.1.8 INSULET CORPORATION
TABLE 145 INSULET CORPORATION: COMPANY OVERVIEW
FIGURE 55 INSULET CORPORATION: COMPANY SNAPSHOT (2022)
10.1.9 BIOCON LIMITED
TABLE 146 BIOCON LIMITED: COMPANY OVERVIEW
FIGURE 56 BIOCON LIMITED: COMPANY SNAPSHOT (2022)
10.1.10 ROCHE DIABETES CARE
TABLE 147 F. HOFFMANN-LA ROCHE: COMPANY OVERVIEW
FIGURE 57 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2022)
10.1.11 OWEN MUMFORD
TABLE 148 OWEN MUMFORD: COMPANY OVERVIEW
10.1.12 MEDTRUM TECHNOLOGIES INC.
TABLE 149 MEDTRUM TECHNOLOGIES INC.: COMPANY OVERVIEW
10.1.13 TERUMO CORPORATION
TABLE 150 TERUMO CORPORATION: COMPANY OVERVIEW
FIGURE 58 TERUMO CORPORATION: COMPANY SNAPSHOT (2021)
10.1.14 WOCKHARDT
TABLE 151 WOCKHARDT: COMPANY OVERVIEW
FIGURE 59 WOCKHARDT: COMPANY SNAPSHOT (2021)
*Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
10.2 OTHER PLAYERS
10.2.1 CEQUR CORPORATION
10.2.2 EOFLOW CO., LTD.
10.2.3 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD
10.2.4 SOOIL DEVELOPMENTS CO., LTD
10.2.5 SUNGSHIM MEDICAL CO., LTD.
10.2.6 VICENTRA B.V.
10.2.7 DEBIOTECH SA
10.2.8 JIANGSU DELFU MEDICAL DEVICE CO., LTD
10.2.9 HASELMEIER
10.2.10 MANNKIND CORPORATION
10.2.11 HTL-STREFA S.A.
11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 CUSTOMIZATION OPTIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS 12.5.2 SOUTH AFRICA
12.5.2.1 Adoption of stricter emission norms and local manufacturing to drive market
TABLE 238 SOUTH AFRICA: PHEV POWERTRAIN MARKET, BY COMPONENT, 2018–2022 (USD MILLION)
TABLE 239 SOUTH AFRICA: PHEV POWERTRAIN MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
TABLE 240 SOUTH AFRICA: BEV POWERTRAIN MARKET, BY COMPONENT, 2018–2022 (USD MILLION)
TABLE 241 SOUTH AFRICA: BEV POWERTRAIN MARKET, BY COMPONENT, 2023–2030 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 ELECTRIC POWERTRAIN MARKET SHARE ANALYSIS, 2022
FIGURE 36 ELECTRIC POWERTRAIN MARKET SHARE ANALYSIS, 2022
FIGURE 37 REVENUE ANALYSIS OF TOP LISTED/PUBLIC PLAYERS: 2020–2022
13.3 COMPANY EVALUATION MATRIX: ELECTRIC POWERTRAIN MANUFACTURERS
13.3.1 STARS
13.3.2 EMERGING LEADERS
13.3.3 PERVASIVE PLAYERS
13.3.4 PARTICIPANTS
FIGURE 38 COMPETITIVE EVALUATION MATRIX (ELECTRIC POWERTRAIN MANUFACTURERS), 2022
TABLE 242 COMPANIES ADOPTED NEW PRODUCT DEVELOPMENTS AND EXPANSIONS AS KEY GROWTH STRATEGIES, 2022–2023
13.4 COMPETITIVE SCENARIO
13.4.1 NEW PRODUCT LAUNCHES
13.5 PRODUCT LAUNCHES
TABLE 243 PRODUCT LAUNCHES, 2021–2023
13.6 DEALS
TABLE 244 DEALS, 2021–2023
13.7 OTHERS
TABLE 245 OTHERS, 2022–2023
13.8 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2023
TABLE 246 KEY GROWTH STRATEGIES, 2022–2023
13.9 COMPETITIVE BENCHMARKING
TABLE 247 ELECTRIC POWERTRAIN MARKET: COMPETITIVE BENCHMARKING
13.10 LIST OF KEY START-UPS/SMES
TABLE 248 ELECTRIC POWERTRAIN MANUFACTURERS: LIST OF KEY START-UPS/SMES
14 COMPANY PROFILES
14.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 ROBERT BOSCH GMBH
TABLE 249 ROBERT BOSCH GMBH: COMPANY OVERVIEW
FIGURE 39 ROBERT BOSCH GMBH: COMPANY SNAPSHOT
TABLE 250 ROBERT BOSCH GMBH: PRODUCTS OFFERED
TABLE 251 ROBERT BOSCH GMBH: NEW PRODUCT DEVELOPMENTS
TABLE 252 ROBERT BOSCH GMBH: DEALS
TABLE 253 ROBERT BOSCH GMBH: OTHERS
14.1.2 MITSUBISHI ELECTRIC CORPORATION
TABLE 254 MITSUBISHI ELECTRIC CORPORATION: COMPANY OVERVIEW
FIGURE 40 MITSUBISHI ELECTRIC CORPORATION: COMPANY SNAPSHOT
TABLE 255 MITSUBISHI ELECTRIC CORPORATION: PRODUCTS OFFERED
TABLE 256 MITSUBISHI ELECTRIC CORPORATION: NEW PRODUCT DEVELOPMENTS
TABLE 257 MITSUBISHI ELECTRIC CORPORATION: DEALS
TABLE 258 MITSUBISHI ELECTRIC CORPORATION: OTHERS
14.1.3 MAGNA INTERNATIONAL INC.
TABLE 259 MAGNA INTERNATIONAL INC.: COMPANY OVERVIEW
FIGURE 41 MAGNA INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 260 MAGNA INTERNATIONAL INC.: PRODUCTS OFFERED
TABLE 261 MAGNA INTERNATIONAL INC.: NEW PRODUCT DEVELOPMENTS
TABLE 262 MAGNA INTERNATIONAL INC.: DEALS
TABLE 263 MAGNA INTERNATIONAL INC.: OTHERS
14.1.4 CONTINENTAL AG
TABLE 264 CONTINENTAL AG: COMPANY OVERVIEW
FIGURE 42 CONTINENTAL AG: COMPANY SNAPSHOT
TABLE 265 CONTINENTAL AG: PRODUCTS OFFERED
TABLE 266 CONTINENTAL AG: NEW PRODUCT DEVELOPMENTS
TABLE 267 CONTINENTAL AG: DEALS
TABLE 268 CONTINENTAL AG: OTHERS
14.1.5 HITACHI ASTEMO, LTD.
TABLE 269 HITACHI ASTEMO, LTD.: COMPANY OVERVIEW
FIGURE 43 HITACHI ASTEMO, LTD.: COMPANY SNAPSHOT
TABLE 270 HITACHI ASTEMO, LTD: PRODUCTS OFFERED
TABLE 271 HITACHI ASTEMO, LTD.: NEW PRODUCT DEVELOPMENTS
TABLE 272 HITACHI ASTEMO, LTD.: DEALS
TABLE 273 HITACHI ASTEMO, LTD.: OTHERS
14.1.6 BORGWARNER INC.
TABLE 274 BORGWARNER INC.: COMPANY OVERVIEW
FIGURE 44 BORGWARNER INC.: COMPANY SNAPSHOT
TABLE 275 BORGWARNER INC.: PRODUCTS OFFERED
TABLE 276 BORGWARNER INC.: NEW PRODUCT DEVELOPMENTS
TABLE 277 BORGWARNER INC.: DEALS
TABLE 278 BORGWARNER INC.: OTHERS
14.1.7 ZF FRIEDRICHSHAFEN AG
FIGURE 45 ZF FRIEDRICHSHAFEN AG: COMPANY SNAPSHOT
TABLE 279 ZF FRIEDRICHSHAFEN AG: PRODUCTS OFFERED
TABLE 280 ZF FRIEDRICHSHAFEN AG: NEW PRODUCT DEVELOPMENTS
TABLE 281 ZF FRIEDRICHSHAFEN AG: DEALS
TABLE 282 ZF FRIEDRICHSHAFEN AG: OTHERS
14.1.8 DENSO CORPORATION
TABLE 283 DENSO CORPORATION: COMPANY OVERVIEW
FIGURE 46 DENSO CORPORATION: COMPANY SNAPSHOT
TABLE 284 DENSO CORPORATION: PRODUCTS OFFERED
TABLE 285 DENSO CORPORATION: NEW PRODUCT DEVELOPMENTS
TABLE 286 DENSO CORPORATION: DEALS
TABLE 287 DENSO CORPORATION: OTHERS
14.1.9 DANA INCORPORATED
TABLE 288 DANA INCORPORATED: COMPANY OVERVIEW
FIGURE 47 DANA INCORPORATED: COMPANY SNAPSHOT
TABLE 289 DANA INCORPORATED: PRODUCTS OFFERED
TABLE 290 DANA INCORPORATED: NEW PRODUCT DEVELOPMENTS
TABLE 291 DANA INCORPORATED: DEALS
TABLE 292 DANA INCORPORATED: OTHERS
14.1.10 VALEO S.A.
TABLE 293 VALEO S.A.: COMPANY OVERVIEW
FIGURE 48 VALEO S.A.: COMPANY SNAPSHOT
TABLE 294 VALEO S.A.: PRODUCTS OFFERED
TABLE 295 VALEO S.A.: NEW PRODUCT DEVELOPMENTS
TABLE 296 VALEO S.A.: DEALS
14.2 OTHER PLAYERS
14.2.1 BRUSA ELEKTRONIK AG
TABLE 297 BRUSA ELEKTRONIK AG: COMPANY OVERVIEW
14.2.2 KELLY CONTROLS
TABLE 298 KELLY CONTROLS: COMPANY OVERVIEW
14.2.3 NIDEC CORPORATION
TABLE 299 NIDEC CORPORATION: COMPANY OVERVIEW
14.2.4 MAGNETI MARELLI CK HOLDINGS
TABLE 300 MAGNETI MARELLI CK HOLDINGS: COMPANY OVERVIEW
14.2.5 TOYOTA INDUSTRIES CORPORATION
TABLE 301 TOYOTA INDUSTRIES CORPORATION: COMPANY OVERVIEW
14.2.6 PANASONIC
TABLE 302 PANASONIC: COMPANY OVERVIEW
14.2.7 CURTIS INSTRUMENTS
TABLE 303 CURTIS INSTRUMENTS: COMPANY OVERVIEW
14.2.8 FILTRAN LLC
TABLE 304 FILTRAN LLC: COMPANY OVERVIEW
14.2.9 MAGTEC
TABLE 305 MAGTEC: COMPANY OVERVIEW
14.2.10 CASCADIA MOTION
TABLE 306 CASCADIA MOTION: COMPANY OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 COMPANY PROFILES: EV BATTERY MARKET
15.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
15.1.1 CATL
TABLE 307 CATL: BUSINESS OVERVIEW
FIGURE 49 CATL: COMPANY SNAPSHOT
TABLE 308 CATL: SUPPLY AGREEMENTS
TABLE 309 CATL: PRODUCTS OFFERED
TABLE 310 CATL: NEW PRODUCT DEVELOPMENTS
TABLE 311 CATL: DEALS
TABLE 312 CATL: OTHERS
15.1.2 SAMSUNG SDI
TABLE 313 SAMSUNG SDI: BUSINESS OVERVIEW
FIGURE 50 SAMSUNG SDI: COMPANY SNAPSHOT
TABLE 314 SAMSUNG SDI: SUPPLY AGREEMENTS
TABLE 315 SAMSUNG SDI: PRODUCTS OFFERED
TABLE 316 SAMSUNG SDI: NEW PRODUCT DEVELOPMENTS
TABLE 317 SAMSUNG SDI: DEALS
TABLE 318 SAMSUNG SDI: OTHERS
15.1.3 PANASONIC HOLDINGS CORPORATION
TABLE 319 PANASONIC HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 51 PANASONIC HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 320 PANASONIC HOLDINGS CORPORATION: SUPPLY AGREEMENTS
TABLE 321 PANASONIC HOLDINGS CORPORATION: PRODUCTS OFFERED
TABLE 322 PANASONIC HOLDINGS CORPORATION: NEW PRODUCT DEVELOPMENTS
TABLE 323 PANASONIC HOLDINGS CORPORATION: DEALS
TABLE 324 PANASONIC HOLDINGS CORPORATION: OTHERS
15.1.4 LG CHEM
TABLE 325 LG CHEM: BUSINESS OVERVIEW
TABLE 326 LG CHEM: R&D OVERVIEW
FIGURE 52 LG CHEM: COMPANY SNAPSHOT
TABLE 327 LG CHEM.: SUPPLY AGREEMENTS
TABLE 328 LG CHEM: PRODUCTS OFFERED
TABLE 329 LG CHEM: NEW PRODUCT DEVELOPMENTS
TABLE 330 LG CHEM: DEALS
TABLE 331 LG CHEM: OTHERS
15.1.5 BYD COMPANY LIMITED
TABLE 332 BYD COMPANY LIMITED: BUSINESS OVERVIEW
FIGURE 53 BYD COMPANY LIMITED: COMPANY SNAPSHOT
TABLE 333 BYD COMPANY LIMITED: PRODUCTS OFFERED
TABLE 334 BYD: NEW PRODUCT DEVELOPMENTS
TABLE 335 BYD: DEALS
TABLE 336 BYD: OTHERS
15.2 MID-TIER PLAYERS
15.2.1 SK INNOVATION CO. LTD.
TABLE 337 SK INNOVATION CO. LTD.: BUSINESS OVERVIEW
FIGURE 54 SK INNOVATION CO. LTD.: COMPANY SNAPSHOT
TABLE 338 SK INNOVATION CO. LTD.: SUPPLY AGREEMENTS
TABLE 339 SK INNOVATION CO. LTD.: PRODUCTS OFFERED
TABLE 340 SK INNOVATION CO. LTD.: NEW PRODUCT DEVELOPMENTS
TABLE 341 SK INNOVATION CO. LTD.: DEALS
TABLE 342 SK INNOVATION CO. LTD.: OTHERS
15.2.2 VEHICLE ENERGY JAPAN INC.
TABLE 343 VEHICLE ENERGY JAPAN INC.: BUSINESS OVERVIEW
TABLE 344 VEHICLE ENERGY JAPAN INC.: SUPPLY AGREEMENTS
TABLE 345 VEHICLE ENERGY JAPAN INC.: PRODUCTS OFFERED
TABLE 346 VEHICLE ENERGY JAPAN INC.: DEALS
TABLE 347 VEHICLE ENERGY JAPAN INC.: OTHERS
15.2.3 TOSHIBA CORPORATION
TABLE 348 TOSHIBA CORPORATION: BUSINESS OVERVIEW
TABLE 349 TOSHIBA CORPORATION: SUPPLY AGREEMENTS
TABLE 350 TOSHIBA CORPORATION: PRODUCTS OFFERED
TABLE 351 TOSHIBA CORPORATION: NEW PRODUCT DEVELOPMENTS
TABLE 352 TOSHIBA CORPORATION: DEALS
TABLE 353 TOSHIBA CORPORATION: OTHERS
15.2.4 MITSUBISHI CORPORATION
TABLE 354 MITSUBISHI CORPORATION: BUSINESS OVERVIEW
TABLE 355 MITSUBISHI CORPORATION: PRODUCTS OFFERED
TABLE 356 MITSUBISHI CORPORATION: NEW PRODUCT DEVELOPMENT
TABLE 357 MITSUBISHI CORPORATION: DEALS
TABLE 358 MITSUBISHI CORPORATION: OTHERS
15.2.5 ENERSYS
TABLE 359 ENERSYS: BUSINESS OVERVIEW
TABLE 360 ENERSYS: PRODUCTS OFFERED
TABLE 361 ENERSYS: NEW PRODUCT DEVELOPMENTS
TABLE 362 ENERSYS: DEALS
15.3 START-UPS
15.3.1 NORTHVOLT AB
TABLE 363 NORTHVOLT AB: BUSINESS OVERVIEW
15.3.2 AUTOMOTIVE CELLS COMPANY
TABLE 364 AUTOMOTIVE CELL COMPANY: BUSINESS OVERVIEW
15.3.3 BLUEOVAL SK
TABLE 365 BLUEOVAL SK: BUSINESS OVERVIEW
15.3.4 CELLFORCE GROUP GMBH
TABLE 366 CELLFORCE GROUP GMBH: BUSINESS OVERVIEW
15.3.5 GOTION HI-TECH
TABLE 367 GOTION HI-TECH: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
16 COMPANY PROFILES: AUTOMOTIVE TRACTION MOTOR MARKET
16.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
16.1.1 BORGWARNER INC.
TABLE 368 BORGWARNER INC.: BUSINESS OVERVIEW
FIGURE 55 BORGWARNER INC.: COMPANY SNAPSHOT
TABLE 369 BORGWARNER INC.: SUPPLY AGREEMENTS
TABLE 370 BORGWARNER INC.: PRODUCTS OFFERED
TABLE 371 BORGWARNER INC.: NEW PRODUCT DEVELOPMENTS
TABLE 372 BORGWARNER INC.: DEALS
TABLE 373 BORGWARNER INC.: OTHERS
16.1.2 BYD CO., LTD.
TABLE 374 BYD CO., LTD.: BUSINESS OVERVIEW
FIGURE 56 BYD CO., LTD.: COMPANY SNAPSHOT
TABLE 375 BYD CO., LTD.: SUPPLY AGREEMENTS
TABLE 376 BYD CO., LTD.: PRODUCTS OFFERED
TABLE 377 BYD CO., LTD.: NEW PRODUCT DEVELOPMENTS
TABLE 378 BYD CO., LTD.: DEALS
TABLE 379 BYD CO., LTD.: OTHERS
16.1.3 SCHAEFFLER GROUP
TABLE 380 SCHAEFFLER GROUP: BUSINESS OVERVIEW
FIGURE 57 SCHAEFFLER GROUP: COMPANY SNAPSHOT
TABLE 381 SCHAEFFLER GROUP: SUPPLY AGREEMENTS
TABLE 382 SCHAEFFLER GROUP: PRODUCTS OFFERED
TABLE 383 SCHAEFFLER GROUP: NEW PRODUCT DEVELOPMENTS
TABLE 384 SCHAEFFLER GROUP: DEALS
TABLE 385 SCHAEFFLER GROUP: OTHERS
16.1.4 ROBERT BOSCH GMBH
TABLE 386 ROBERT BOSCH GMBH: BUSINESS OVERVIEW
FIGURE 58 ROBERT BOSCH GMBH: COMPANY SNAPSHOT
TABLE 387 ROBERT BOSCH GMBH: SUPPLY AGREEMENTS
TABLE 388 ROBERT BOSCH GMBH: PRODUCTS OFFERED
TABLE 389 ROBERT BOSCH GMBH: NEW PRODUCT DEVELOPMENTS
TABLE 390 ROBERT BOSCH GMBH: DEALS
TABLE 391 ROBERT BOSCH GMBH: OTHERS
16.1.5 ZF FRIEDRICHSHAFEN AG
TABLE 392 ZF FRIEDRICHSHAFEN AG: BUSINESS OVERVIEW
FIGURE 59 ZF FRIEDRICHSHAFEN AG: COMPANY SNAPSHOT
TABLE 393 ZF FRIEDRICHSHAFEN AG: SUPPLY AGREEMENTS
TABLE 394 ZF FRIEDRICHSHAFEN AG: PRODUCTS OFFERED
TABLE 395 ZF FRIEDRICHSHAFEN AG: NEW PRODUCT DEVELOPMENTS
TABLE 396 ZF FRIEDRICHSHAFEN AG: DEALS
TABLE 397 ZF FRIEDRICHSHAFEN AG: OTHERS
16.2 MID-TIER PLAYERS
16.2.1 JOHNSON ELECTRIC HOLDINGS LTD.
TABLE 398 JOHNSON ELECTRIC HOLDINGS LTD.: BUSINESS OVERVIEW
FIGURE 60 JOHNSON ELECTRIC HOLDINGS LTD.: COMPANY SNAPSHOT
TABLE 399 JOHNSON ELECTRIC HOLDINGS LTD.: PRODUCTS OFFERED
TABLE 400 JOHNSON ELECTRIC: OTHER DEVELOPMENTS
16.2.2 CONTINENTAL AG
TABLE 401 CONTINENTAL AG: BUSINESS OVERVIEW
FIGURE 61 CONTINENTAL AG: COMPANY SNAPSHOT
TABLE 402 CONTINENTAL AG: SUPPLY AGREEMENTS
TABLE 403 CONTINENTAL AG: PRODUCTS OFFERED
TABLE 404 CONTINENTAL AG: NEW PRODUCT DEVELOPMENTS
TABLE 405 CONTINENTAL AG: OTHERS
16.2.3 VALEO S.A.
TABLE 406 VALEO S.A.: BUSINESS OVERVIEW
FIGURE 62 VALEO S.A.: COMPANY SNAPSHOT
TABLE 407 VALEO S.A.: SUPPLY AGREEMENTS
TABLE 408 VALEO S.A.: PRODUCTS OFFERED
TABLE 409 VALEO S.A.: NEW PRODUCT DEVELOPMENT
TABLE 410 VALEO S.A.: DEALS
16.2.4 MAHLE GROUP
TABLE 411 MAHLE GROUP: BUSINESS OVERVIEW
FIGURE 63 MAHLE GROUP: COMPANY SNAPSHOT
TABLE 412 MAHLE GROUP: PRODUCTS OFFERED
TABLE 413 MAHLE GROUP: NEW PRODUCT DEVELOPMENT
TABLE 414 MAHLE GROUP: DEALS
TABLE 415 MAHLE GROUP: OTHERS
16.2.5 NIDEC CORPORATION
TABLE 416 NIDEC CORPORATION: BUSINESS OVERVIEW
FIGURE 64 NIDEC CORPORATION: COMPANY SNAPSHOT
TABLE 417 NIDEC CORPORATION: SUPPLY AGREEMENTS
TABLE 418 NIDEC CORPORATION: PRODUCTS OFFERED
TABLE 419 NIDEC CORPORATION: NEW PRODUCT DEVELOPMENTS
TABLE 420 NIDEC CORPORATION: DEALS
TABLE 421 NIDEC CORPORATION: OTHERS
16.3 OTHER PLAYERS
16.3.1 JING-JIN ELECTRIC
TABLE 422 JING-JIN ELECTRIC: BUSINESS OVERVIEW
16.3.2 SHANGHAI EDRIVE CO., LTD.
TABLE 423 SHANGHAI EDRIVE CO., LTD.: BUSINESS OVERVIEW
16.3.3 XPT WEILAI DRIVE TECHNOLOGY
TABLE 424 XPT WEILAI DRIVE TECHNOLOGY: BUSINESS OVERVIEW
16.3.4 ZHUHAI ENPOWER ELECTRIC CO., LTD.
TABLE 425 ZHUHAI ENPOWER ELECTRIC CO., LTD.: BUSINESS OVERVIEW
16.3.5 ANAND MANDO EMOBILITY
TABLE 426 ANAND MANDO EMOBILITY: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
17 RECOMMENDATIONS BY MARKETS AND MARKETS
17.1 ASIA PACIFIC TO BE MAJOR MARKET FOR ELECTRIC POWERTRAINS
17.2 BEV POWERTRAIN COMPONENTS CAN BE KEY FOCUS FOR MANUFACTURERS
17.3 CONCLUSION
18 APPENDIX
18.1 KEY INDUSTRY INSIGHTS
18.2 DISCUSSION GUIDE
18.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
18.4 CUSTOMIZATION OPTIONS
18.4.1 ELECTRIC POWERTRAIN MARKET, BY VEHICLE TYPE
18.4.1.1 BEV
18.4.1.2 HEV/PHEV
18.4.1.3 FCEV
18.4.2 ELECTRIC POWERTRAIN MARKET, BY TYPE
18.4.2.1 BEV powertrain
18.4.2.2 Series hybrid powertrain
18.4.2.3 Parallel hybrid powertrain
18.4.2.4 Series-parallel hybrid powertrain
18.5 RELATED REPORTS
18.6 AUTHOR DETAILS
